Skip to main content
SpringerLink
Log in

Acute Revascularization in ST-Segment-Elevation Myocardial Infarction

  • Cardiovascular Disease and Stroke (P Perrone-Filardi and S. Agewall, Section Editors)
  • Published:
Current Atherosclerosis Reports Aims and scope Submit manuscript

Abstract

We briefly and comprehensively present some of the novel findings in the field of revascularization therapy and management of ST-segment-elevation myocardial infarction (STEMI). We highlight the latest evidence-based advancements in the pharmacological and mechanical treatment of patients who presented with STEMI. Since the last updates to the international guidelines (American College of Cardiology/American Heart Association and the European Society of Cardiology) were published in 2011 and 2012, there have been changes and several important studies have presented their final outcomes. We also highlight some controversial approaches as part of the current debates in the cardiology community. In addition, we share our recent experience in the field of biodegradable scaffold stents as a treatment strategy in STEMI.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. Heart disease and stroke statistics—2014 update: a report from the American Heart Association. Circulation. 2013. doi:10.1161/01.cir.0000441139.02102.80.

    PubMed Central  Google Scholar 

  2. Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med. 2010;362:2155–65.

    Article  CAS  PubMed  Google Scholar 

  3. Widimsky P, Wijns W, Fajadet J, de Belder M, Knot J, Aaberge L, et al. Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries. Eur Heart J. 2010;31(8):943–57.

    Article  PubMed Central  PubMed  Google Scholar 

  4. Puymirat E, Simon T, Steg PG, Schiele F, Guéret P, Blanchard D, et al. Association of changes in clinical characteristics and management with improvement in survival among patients with ST-elevation myocardial infarction. JAMA. 2012;308(10):998–1006.

    Article  CAS  PubMed  Google Scholar 

  5. Steg PG, James SK, Atar D, Badano LP, Blomstrom-Lundqvist C, Borger MA, et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33:2569–619.

    Article  CAS  PubMed  Google Scholar 

  6. Knot J, Widimsky P, Wijns W, Stenestrand U, Kristensen SD, van’t Hof A, et al. How to set up an effective national primary angioplasty network: lessons learned from five European countries. EuroIntervention. 2009;5(3):299. 301-9.

    PubMed  Google Scholar 

  7. Bagai A, Jollis JG, Dauerman HL, Peng SA, Rokos IC, Bates ER, et al. Emergency department bypass for ST-segment-elevation myocardial infarction patients identified with a prehospital electrocardiogram: a report from the American Heart Association Mission: Lifeline Program. Circulation. 2013;128(4):352–9.

    Article  PubMed  Google Scholar 

  8. Concannon TW, Nelson J, Kent DM, Griffith JL. Evidence of systematic duplication by new percutaneous coronary intervention programs. Circ Cardiovasc Qual Outcome. 2013;6(4):400–8.

    Article  Google Scholar 

  9. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361(9351):13–20.

    Article  PubMed  Google Scholar 

  10. Armstrong PW, Gershlick AH, Goldstein P, Wilcox R, Danays T, Lambert Y, et al. Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. N Engl J Med. 2013;368(15):1379–87.

    Article  CAS  PubMed  Google Scholar 

  11. Halvorsen S, Huber K. Fibrinolytic treatment of ST-elevation myocardial infarction. Update 2014. Hamostaseologie. 2013;34(1):47–53.

    Article  PubMed  Google Scholar 

  12. Suryapranata H, van't Hof AW, Hoorntje JC, de Boer MJ, Zijlstra F. Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction. Circulation. 1998;97(25):2502–5.

    Article  CAS  PubMed  Google Scholar 

  13. Sasao H, Tsuchihashi K, Nagao K, Miyamoto K, Murakami H, Doi A, et al. Long-term outcome after primary stenting versus balloon angioplasty for acute myocardial infarction five-year follow-up of a case-control study. Int Heart J. 2006;47(1):47–57.

    Article  PubMed  Google Scholar 

  14. Möckel M, Vollert J, Lansky AJ, Witzenbichler B, Guagliumi G, Peruga JZ, et al. Comparison of direct stenting with conventional stent implantation in acute myocardial infarction. Am J Cardiol. 2011;108(12):1697–703.

    Article  PubMed  Google Scholar 

  15. Loubeyre C, Morice MC, Lefèvre T, Piéchaud JF, Louvard Y, Dumas P. A randomized comparison of direct stenting with conventional stent implantation in selected patients with acute myocardial infarction. Am Coll Cardiol. 2002;39(1):15–21.

    Article  Google Scholar 

  16. Brito Jr FS, Caixeta AM, Perin MA, Rati M, Arruda JA, Cantarelli M, et al. Comparison of direct stenting versus stenting with predilation for the treatment of selected coronary narrowings. Am J Cardiol. 2002;89(2):115–20.

    Article  PubMed  Google Scholar 

  17. Palmerini T, Biondi-Zoccai G, Della Riva D, Mariani A, Sabaté M, Valgimigli M, et al. Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis. J Am Coll Cardiol. 2013;62:496–504.

    Article  CAS  PubMed  Google Scholar 

  18. Garg A, Brodie BR, Stuckey TD, Garberich RF, Tobbia P, Hansen C, et al. New generation drug-eluting stents for ST-Elevation myocardial infarction: a new paradigm for safety. Catheter Cardiovasc Interv. 2013. doi:10.1002/ccd.25280.

    Google Scholar 

  19. Park KW, Kang S, Velders MA, Shin D, Hahn S, Lim W, et al. Safety and efficacy of everolimus- versus sirolimus-eluting stents: a systematic review and meta-analysis of 11 randomized trials. Am Heart J. 2013;165:241–50.e4.

    Article  CAS  PubMed  Google Scholar 

  20. Sabate M, Cequier A, Iñiguez A, Serra A, Hernandez-Antolin R, Mainar V, et al. Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial. Lancet. 2012;380(9852):1482–90.

    Article  CAS  PubMed  Google Scholar 

  21. Park KW, Lee JM, Kang SH, Ahn HS, Yang HM, Lee HY, et al. Safety and efficacy of second-generation everolimus-eluting Xience V stents versus zotarolimus-eluting resolute stents in real-world practice: patient-related and stent-related outcomes from the multicenter prospective EXCELLENT and RESOLUTE-Korea registries. J Am Coll Cardiol. 2013;61(5):536–44.

    Article  CAS  PubMed  Google Scholar 

  22. Belardi JA, Widimský P, Neumann FJ, Mauri L, Albertal M. Real-world safety and effectiveness outcomes of a zotarolimus-eluting stent: final 3-year report of the RESOLUTE International study. J Interv Cardiol. 2013;26(5):515–23.

    PubMed  Google Scholar 

  23. Bangalore S, Toklu B, Amoroso N, Fusaro M, Kumar S, Hannan EL, et al. Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis. BMJ. 2013;347:f6625.

    Article  PubMed Central  PubMed  Google Scholar 

  24. Kocka V, Maly M, Tousek P, Budesínsky T, Lisa L, Prodanov P, et al. Bioresorbable vascular scaffolds in acute ST-segment elevation myocardial infarction: a prospective multicentre study 'Prague 19’. Eur Heart J. 2014. doi:10.1093/eurheartj/eht545. This is the first prospective study testing the use of Biodegradable vascular scaffolds in patients with STEMI. The early outcomes demonstrated in this study are encouraging for the use of BVS in patients with STEMI. Longer follow up will confirm whether these early results are maintained.

    PubMed Central  PubMed  Google Scholar 

  25. Wiebe J, Möllmann H, Most A, Dörr O, Weipert K, Rixe J, et al. Short-term outcome of patients with ST-segment elevation myocardial infarction (STEMI) treated with an everolimus-eluting bioresorbable vascular scaffold. Clin Res Cardiol. 2014;103:141–8.

    Article  CAS  PubMed  Google Scholar 

  26. O’Gara PT, Kushner FG, Ascheim DD, Casey DE, Chung MK, de Lemos JA, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;61:e78–140.

    Article  PubMed  Google Scholar 

  27. Widimsky P, Holmes Jr DR. How to treat patients with ST-elevation acute myocardial infarction and multi-vessel disease? Eur Heart J. 2011;32(4):396–403. Until there are published results of clinical trials, this study very comprehensively summarizes the international experience in the field.

    Article  PubMed Central  PubMed  Google Scholar 

  28. Toma M, Buller CE, Westerhout CM, Fu Y, O'Neill WW, Holmes Jr DR, et al. Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insights from the APEX-AMI trial. Eur Heart J. 2010;31(14):1701–7.

    Article  PubMed  Google Scholar 

  29. Wald DS, Morris JK, Wald NJ, Chase AJ, Edwards RJ, Hughes LO, et al. Randomized trial of preventive angioplasty in myocardial infarction. N Engl J Med. 2013;369(12):1115–23.

    Article  CAS  PubMed  Google Scholar 

  30. Montalescot G, Wiviott SD, Braunwald E, Murphy SA, Gibson CM, McCabe CH, et al. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial. Lancet. 2009;373(9665):723–31.

    Article  CAS  PubMed  Google Scholar 

  31. Steg PG, James S, Harrington RA, Ardissino D, Becker RC, Cannon CP, et al. Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: a Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis. Circulation. 2010;122(21):2131–41.

    Article  PubMed  Google Scholar 

  32. Valgimigli M, Park SJ, Kim HS, Park KW, Park DW, Tricoci P, et al. Benefits and risks of long-term duration of dual antiplatelet therapy after drug-eluting stenting: a meta-analysis of randomized trials. Int J Cardiol. 2013;168(3):2579–87.

    Article  PubMed  Google Scholar 

  33. Desai NR, Bhatt DL. The state of periprocedural antiplatelet therapy after recent trials. J Am Coll Cardiol Interv. 2010;3(6):571–83.

    Article  Google Scholar 

  34. Thiele H, Wöhrle J, Hambrecht R, Rittger H, Birkemeyer R, Lauer B, et al. Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a randomised trial. Lancet. 2012;379(9819):923–31.

    Article  CAS  PubMed  Google Scholar 

  35. Shah A, Feldman DN. Outcome of the HORIZONS-AMI trial: bivalirudin enhances long-term survival in patients with ST-elevation myocardial infarction undergoing angioplasty. Vasc Health Risk Manag. 2012;8:115–23.

    CAS  PubMed Central  PubMed  Google Scholar 

  36. Bhatt DL, Stone GW, Mahaffey KW, Gibson CM, Steg PG, Hamm CW, et al. Effect of platelet inhibition with cangrelor during PCI on ischemic events. N Engl J Med. 2013;368(14):1303–13.

    Article  CAS  PubMed  Google Scholar 

  37. Gu YL, van der Horst IC, Douglas YL, Svilaas T, Mariani MA, Zijlstra F. Role of coronary artery bypass grafting during the acute and subacute phase of ST-elevation myocardial infarction. Neth Heart J. 2010;18(7–8):348–54.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  38. Stone GW, Brodie BR, Griffin JJ, Grines L, Boura J, O'Neill WW, et al. Role of cardiac surgery in the hospital phase management of patients treated with primary angioplasty for acute myocardial infarction. Am J Cardiol. 2000;85(11):1292–6.

    Article  CAS  PubMed  Google Scholar 

  39. Nikolsky E, McLaurin BT, Cox DA, Manoukian SV, Xu K, Mehran R, et al. Outcomes of patients with prior coronary artery bypass grafting and acute coronary syndromes: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. JACC Cardiovasc Interv. 2012;5(9):919–26.

    Article  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

XPetko Prodanov declares that he has no conflict of interest.

Petr Widimsky has consulted for Abbott, Medtronic, Eli Lilly, Daiichi Sankyo, and AstraZeneca, and has received honoraria from Servier, Sanofi, Bayer, and Boehringer Ingelheim.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. Cardiocenter, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Srobarova 50 str., 100 34, Prague 10, Czech Republic

    Petko Prodanov & Petr Widimsky

Authors
  1. Petko Prodanov
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Petr Widimsky
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Petko Prodanov or Petr Widimsky.

Additional information

This article is part of the Topical Collection on Cardiovascular Disease and Stroke

Rights and permissions

Reprints and permissions

About this article

Cite this article

Prodanov, P., Widimsky, P. Acute Revascularization in ST-Segment-Elevation Myocardial Infarction. Curr Atheroscler Rep 16, 412 (2014). https://doi.org/10.1007/s11883-014-0412-6

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11883-014-0412-6

Keywords

Search

Navigation